Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases

Respirology

Volumn 20, Issue 5, 2015, Pages 805-812

  Tanabe, Nobuhiro ^a   Taniguchi, Hiroyuki ^b   Tsujino, Ichizo ^c   Sakamaki, Fumio ^d   Emoto, Noriaki ^e   Kimura, Hiroshi ^f   Takamura, Kei ^g   Hanaoka, Masayuki ^h   Nishimura, Masaharu ^c   Tatsumi, Koichiro ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOSEI GENERAL HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d SAISEIKAI CENTRAL HOSPITAL   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f NARA MEDICAL UNIVERSITY   (Japan)

^g Obihiro Kosei General Hospital   (Japan)

^h SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic obstructive pulmonary disease; clinical respiratory medicine; nitric oxide; pulmonary circulation and pulmonary hypertension; pulmonary fibrosis

Indexed keywords

BERAPROST; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; AGED; CLINICAL TRIAL; COMPLICATION; HYPERTENSION, PULMONARY; JAPAN; LUNG; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RESPIRATORY TRACT DISEASES; SEVERITY OF ILLNESS INDEX;

AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; JAPAN; LUNG; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PROGNOSIS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84931566548     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12530     Document Type: Article

References (19)

1. Chaouat A, Naeije R, Weitzenblum E,. Pulmonary hypertension in COPD. Eur. Respir. J. 2008; 32: 1371-1385.
2. Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, et-al. Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. Int. J. Cardiol. 154 (Suppl. 1): S45-53.
3. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, et-al. Pulmonary hypertension in chronic lung diseases. J. Am. Coll. Cardiol. 2013; 62 (25 Suppl.): D109-116.
4. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, et-al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62 (25 Suppl.): D34-41.
5. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et-al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2009; 34: 1219-1263.
6. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, et-al. ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a REferral centre. Eur. Respir. J. 2012; 39: 945-955.
7. Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C, et-al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur. Respir. J. 2013; 41: 1292-1301.
8. Tanabe N, Taniguchi H, Tsujino I, Sakamaki F, Emoto N, Kimura H, Miyaji K, Takamura K, Hayashi S, Hanaoka M, et-al. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society. Respir. Investig. 2014; 52: 167-172.
9. Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M,. A randomised, controlled trial of bosentan in severe COPD. Eur. Respir. J. 2008; 32: 619-628.
10. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barberà JA,. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2010; 181: 270-278.
11. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE,. National Emphysema Treatment Trial (NETT) Group: hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314-322.
12. Hinchcliff M, Desai CS, Varga J, Shah SJ,. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin. Exp. Rheumatol. 2012; 30 (2 Suppl. 71): S30-37.
13. Papadopoulos CE, Pitsiou G, Karamitsos TD, Karvounis HI, Kontakiotis T, Giannakoulas G, Efthimiadis GK, Argyropoulou P, Parharidis GE, Bouros D,. Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic [corrected] study. Eur. Respir. J. 2008; 31: 701-706.
14. Lõpez-Sánchez M, Muñoz-Esquerre M, Huertas D, Gonzalez-Costello J, Ribas J, Manresa F, Dorca J, Santos S,. High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study. PLoS ONE 2013; 8: e6803.
15. Mittoo S, Jacob T, Craig A, Bshouty Z,. Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease. Can. Respir. J. 2010; 17: 282-286.
16. The Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N. Engl. J. Med. 2010; 363: 620-628.
17. Han MK, Bach DS, Hagan PG, Yow E, Flaherty KR, Toews GB, Anstrom KJ, Martinez FJ,. IPFnet Investigators: sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest 2013; 143: 1699-1708.
18. Cottin V, Le Pavec J, Prévot G, Mal H, Humbert M, Simonneau G, Cordier JF, GERM«O»P. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105-111.
19. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE,. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum. 2009; 60: 569-577.